To access the Herald’s local coronavirus/COVID-19 coverage, click here.
COURT HOUSE – A spokesperson for Cape Regional Medical Center said that the center is not offering Remdesivir as a treatment for COVID-19 infection at this time.
The drug, touted by several medical professionals as a potentially promising new weapon against the coronavirus virus, has not yet been approved by the Federal Drug Administration (FDA). It is still considered experimental and is only offered in clinical trials.
Public attention to the drug followed a recent statement by Dr. Anthony Fauci, head of the National Institute for Allergy and Infectious Diseases. Fauci said the drug has “a positive effect on diminishing the time to recovery.”
Gilead Sciences, the drug’s maker, is working to expand capacity to produce it, according to public statements by the company CEO Daniel O’Day.
Clinical trials are ongoing and the FDA is considering authorizing emergency use.
